Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Akari Therapeutics Plc (AKTX) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Akari Therapeutics Plc. Table 2 shows the detailed insider transactions. This company's CIK number is 1541157.
Total stock buying since 2015: $257,223.
Total stock sales since 2015: $0.
Total stock option exercises since 2015: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 52,146 | $56,659 | 0 | $0 | 0 | $0 |
| 2015 | 1,055,600 | $200,564 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 21,000 | $19,540 | 0 | $0 | 0 | $0 |
| 2025-06 | 31,146 | $37,119 | 0 | $0 | 0 | $0 |
| 2015-09 | 1,055,600 | $200,564 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-25 | Gaslightwala Abizer (CEO) | Buy | 3,000 | .90 | 2,700 |
| 2025-08-22 | Gaslightwala Abizer (CEO) | Buy | 8,000 | .93 | 7,440 |
| 2025-08-21 | Gaslightwala Abizer (CEO) | Buy | 10,000 | .94 | 9,400 |
| 2025-06-24 | Gaslightwala Abizer (President & CEO) | Buy | 5,203 | 1.16 | 6,035 |
| 2025-06-23 | Gaslightwala Abizer (President & CEO) | Buy | 943 | 1.15 | 1,084 |
| 2025-06-20 | Gaslightwala Abizer (President & CEO) | Buy | 10,000 | 1.20 | 12,000 |
| 2025-06-17 | Gaslightwala Abizer (President & CEO) | Buy | 15,000 | 1.20 | 18,000 |
| 2015-09-18 | Cohen Mark S | Buy | 1,055,600 | .19 | 200,564 |
Insider trading activities including stock purchases, stock sales, and option exercises of AKTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Akari Therapeutics Plc (symbol AKTX, CIK number 1541157) see the Securities and Exchange Commission (SEC) website.